Skip to primary navigation
Skip to main content
Skip to primary sidebar

Join our community
Login

Enter your search

About
Back to Basics
From the Editors
- Expert Commentaries
- Expert Views
News
- Congress Reports
- Journal Updates
Trials
Guidelines
Videos
Slides
Resources

A study of lepodisiran (LY3819469) in participants with elevated Lp(a) (NCT055565742)

You are here: Home > Trials

Primary Sidebar

Please login or create a FREE account to view this content

Email Address*

Password*

Only fill in if you are not human

Keep me signed in

Forgot your password?

Educational Partners and Supporters

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum. (Founding Partner)

Editorial Policy

Unless otherwise indicated, opinions expressed in Lp(a) Education and Research Forum are those of the contributors. All patients should discuss their medication with their healthcare professional. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of Lp(a) Forum, Co-Chairs, Steering Committee, Editorial Advisory Board, Secretariat or Grantors is accepted for the consequences of any misleading or inaccurate information.

© Copyright 2024 Lp(a) Forum. All rights reserved.

Homepage
Privacy Policy
Governance
Disclaimer Statement
Contact